EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic‐Assisted Therapy

Judith Stirn iD, Christian D Klein iD

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Judith Stirn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology IPMB, Heidelberg University, Heidelberg, Germany. Hauptthemen laut MEDLINE: Psilocybin, Tryptamines, Prodrugs. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was financed solely by internal funds of Heidelberg University and the state of Baden-Württemberg..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acyloxymethyl (ACOM) derivatives of tryptamines such as the psychedelic drug psilocin and the anti‐migraine drug sumatriptan bear potential as prodrugs. Previous synthetic approaches suffer from insufficient chemoselectivity between the desired functionalization of the phenolic (psilocin) or sulfonamide (sumatriptan) groups versus other reactive groups in the parent drugs. We report a novel synthetic route toward ACOM prodrugs of tryptamines via the chemoselective installation of a carbamate protecting group at the indole nitrogen by means of a Heller–Sarpong reagent and final deprotection under extremely mild conditions. This enables delicate transformations such as the O ‐acyloxymethylation of psilocin or the N 2 ‐acyloxymethylation of sumatriptan. Several novel O ‐ACOM ethers of hydroxytryptamines were obtained and evaluated in vitro for their potential as novel prodrugs for psychedelic therapy. The rate of bioactivation in human plasma may be adjusted to rapid ( t 1/2 < 1 min) or slow ( t 1/2 > 240 min) kinetics by varying the acyl residue in the ACOM promoiety. Irrespective of the acyl residue, short half‐lives in human saliva will likely preclude the sublingual or buccal application of ACOM ether prodrugs of hydroxytryptamines, while other routes such as peroral, transdermal, nasal, or intravenous administration may be pursued.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsilocybinTryptaminesProdrugsCarbamatesIndolesMolecular StructureSumatriptanDrug Administration RoutesHumans

Stichwörter der Autor:innen

ACOM prodrugbuccal/sublingualpsilocinpsychedelic‐assisted therapytryptamine

Substanzen

psilocinPsilocybinTryptaminesProdrugsCarbamatesIndolesSumatriptan

Autor:innen und Institutionen

  • Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology IPMB, Heidelberg University, Heidelberg, Germany.

ORCID-Profile: Judith Stirn, Christian D Klein

Förderung

  • This work was financed solely by internal funds of Heidelberg University and the state of Baden-Württemberg.

Zitieren

APA

Stirn, J., & Klein, C. D. (2025). Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic‐Assisted Therapy. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70022

Vancouver

Stirn J, Klein CD. Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic‐Assisted Therapy. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70022

BibTeX
@article{Stirn2025,
  author = {Stirn, Judith and Klein, Christian D},
  title = {Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic‐Assisted Therapy},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70022}
}
Kostenlos starten →